Shares of Tilray Inc (NASDAQ:TLRY - Get Free Report) traded down 17.4% during trading on Wednesday . The stock traded as low as $1.99 and last traded at $2.04. 55,547,376 shares changed hands during trading, an increase of 81% from the average session volume of 30,605,016 shares. The stock had previously closed at $2.47.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on TLRY shares. Alliance Global Partners boosted their price target on shares of Tilray from $2.25 to $2.75 and gave the company a "neutral" rating in a report on Friday, April 5th. Canaccord Genuity Group cut their price target on shares of Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a report on Wednesday, April 10th. Finally, CIBC cut their price target on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th.
Read Our Latest Analysis on TLRY
Tilray Trading Down 18.2 %
The company has a current ratio of 1.92, a quick ratio of 1.18 and a debt-to-equity ratio of 0.11. The company's fifty day moving average is $1.97 and its 200-day moving average is $1.94. The firm has a market capitalization of $1.56 billion, a P/E ratio of -4.59 and a beta of 2.36.
Institutional Trading of Tilray
A number of hedge funds have recently bought and sold shares of TLRY. Clear Street Markets LLC bought a new position in shares of Tilray during the 3rd quarter worth about $25,000. Gainplan LLC bought a new position in shares of Tilray during the 4th quarter worth about $28,000. Simplicity Wealth LLC bought a new position in shares of Tilray during the 1st quarter worth about $28,000. RPO LLC acquired a new stake in shares of Tilray during the 4th quarter worth about $28,000. Finally, Great Valley Advisor Group Inc. acquired a new stake in shares of Tilray during the 3rd quarter worth about $29,000. 9.35% of the stock is owned by institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
